Multistage Stochastic Models for Epidemic Resource Allocation: A Comparative Review of Computational Performance and Policy Implications
Received: 15 September 2026 · Revised: 8 October 2026 · Accepted: 11 October 2026 · Published: 13 October 2026
DOI: https://doi.org/10.5281/zenodo.23335180
Download PDFBibTeXRIS (EndNote, Zotero, Mendeley)
Abstract
Background: Epidemic resource allocation requires sequential decisions under uncertain transmission, supply, and behavioral conditions. Published models address these challenges using different objectives and reporting measures, which limits direct comparison. Objective: To organize reported numerical findings from four epidemic resource-allocation model families within a unified mean-risk multistage stochastic programming perspective and to derive transparent comparative indicators without pooling incompatible outcomes. Methods: A structured secondary-data analysis was conducted using reported results from multi-echelon vaccine logistics, equity-aware Ebola allocation, community-level allocation and ventilator planning, and mean-CVaR vaccine-and-treatment logistics. Extracted indicators included predicted infections, infections averted, mixed-integer-programming gap, runtime, stage-wise value of the stochastic solution, mean absolute percentage error, expected deaths, and cost. Runtime speedups and relative cost premium were calculated from reported values. Incomplete observations were not imputed. Results: For the available U.S.-level formulations, predicted infections ranged from 21,515,219 to 21,677,985 and infections averted from 1,702,212 to 1,864,978. Conventional runtimes ranged from 863 to 36,000 s, compared with approximately 12-13 s for decomposition, producing derived speedups of 66-3,000-fold. Stage-wise VSS increased from 0 to 69 objective units. Infection MAPE was 0.06-0.16%, earlier ventilator deployment was associated with approximately 571 fewer expected deaths (1.30%), and an approximately US$0.15 million cost increase on a US$70 million baseline represented a derived premium of 0.21%. Conclusion: Decomposition, adaptive stochastic planning, and explicit tail-risk control offer complementary benefits, but the heterogeneous studies cannot be ranked using a single pooled measure. Shared benchmark instances and standardized reporting are needed for confirmatory comparison.
Keywords: Epidemic resource allocationmultistage stochastic programmingCVaRvaccine logisticsdecompositionVSSequity
How to cite
Shahzaib, Munir, M. A., Bajwa, M. A. I., Wajid, A., & Noman, M. (2026). Multistage Stochastic Models for Epidemic Resource Allocation: A Comparative Review of Computational Performance and Policy Implications. Journal of Biological and Sustainability Sciences, 2(1), 12–19. https://doi.org/10.5281/zenodo.23335180
Funding
No funding was received for this study from any public, commercial or non-profit organization.
Conflicts of interest
The authors declare no conflicts of interest.
Data availability
All analyzed numerical data are available in the cited studies and supplied extraction material.
Ethics approval
Not applicable, as the study used published and aggregate numerical data only.
Informed consent
Not applicable, as the study used published and aggregate numerical data only. Informed consent statement: Not applicable. This study used published aggregate numerical results and involved no human participants or identifiable data.
Author contributions
Shahzaib: Conceptualization, methodology, data curation, and writing—original draft. Abdul Wajid: Conceptualization, literature review, and formal analysis. Muhammad Adnan Munir: Methodology and interpretation of findings. Muhammad Noman: Data validation and interpretation of results. Muhammad Awais Ibrahim Bajwa: Supervision, critical review of the manuscript, and editing. All authors reviewed and approved the final version of the manuscript and agreed to be accountable for all aspects of the work.
Use of artificial intelligence
AI tools were used to assist with language editing and manuscript refinement. The authors take full responsibility for the accuracy, originality, and final content of the manuscript
References
- Jozani K, Sageer NA, Eldardiry H, Tunc S, Buyuktahtakin Toy E. A multi-echelon demand-driven supply chain model for proactive optimal control of epidemics: insights from a COVID-19 study. arXiv. 2025;2510.16969. doi: https://doi.org/10.48550/arXiv.2510.16969.
- Yin X, Buyuktahtakin IE. A multi-stage stochastic programming approach to epidemic resource allocation with equity considerations. Health Care Management Science. 2021;24:597–622. doi: https://doi.org/10.1007/s10729-021-09559-z.
- Bui H, Eksioglu S, Proano R, Shen H. Design of targeted community-based resource allocation in the presence of vaccine hesitancy via a data-driven compartmental stochastic optimization model. arXiv. 2024;2405.05487. doi: https://doi.org/10.48550/arXiv.2405.05487.
- Yin X, Buyuktahtakin IE, Patel BP. COVID-19: data-driven optimal allocation of ventilator supply under uncertainty and risk. European Journal of Operational Research. 2023;304:255–275. doi: https://doi.org/10.1016/j.ejor.2021.11.052.
- Yin X, Buyuktahtakin IE. Risk-averse multi-stage stochastic programming to optimizing vaccine allocation and treatment logistics for effective epidemic response. IISE Transactions on Healthcare Systems Engineering. 2022;12:52–74. doi: https://doi.org/10.1080/24725579.2021.1938298.
- Escudero LF, Garin A, Merino M, Perez G. The value of the stochastic solution in multistage problems. TOP. 2007;15:48–64. doi: https://doi.org/10.1007/s11750-007-0005-4.
- Birge JR, Louveaux F. Introduction to Stochastic Programming. 2nd ed. New York: Springer; 2011. doi:https://doi.org/10.1007/978-1-4614-0237-4.
- Rockafellar RT, Uryasev S. Optimization of conditional value-at-risk. Journal of Risk. 2000;2:21–41. doi: https://doi.org/10.21314/JOR.2000.038.
- Tanner MW, Sattenspiel L, Ntaimo L. Finding optimal vaccination strategies under parameter uncertainty using stochastic programming. Mathematical Biosciences. 2008;215:144–151. doi: https://doi.org/10.1016/j.mbs.2008.07.006.
- Yarmand H, Ivy JS, Denton B, Lloyd AL. Optimal two-phase vaccine allocation to geographically different regions under uncertainty. European Journal of Operational Research. 2014;233:208–219. doi: https://doi.org/10.1016/j.ejor.2013.08.027.
- Thul L, Powell W. Stochastic optimization for vaccine and testing kit allocation for the COVID-19 pandemic. European Journal of Operational Research. 2023;304:325–338. doi: https://doi.org/10.1016/j.ejor.2021.11.007.
- Du M, Sai A, Kong N. A data-driven optimization approach for multi-period resource allocation in cholera outbreak control. European Journal of Operational Research. 2021;291:1106–1116. doi: https://doi.org/10.1016/j.ejor.2020.09.052.
- Buyuktahtakin IE, des-Bordes E, Kibis EY. A new epidemics-logistics model: insights into controlling the Ebola virus disease in West Africa. European Journal of Operational Research. 2018;265:1046–1063. doi: https://doi.org/10.1016/j.ejor.2017.08.037.
- Long EF, Nohdurft E, Spinler S. Spatial resource allocation for emerging epidemics: a comparison of greedy, myopic, and dynamic policies. Manufacturing & Service Operations Management. 2018;20:181–198. doi: https://doi.org/10.1287/msom.2017.0681.
- Liu M, Zhang D. A dynamic logistics model for medical resources allocation in an epidemic control with demand forecast updating. Journal of the Operational Research Society. 2016;67:841–852. doi: https://doi.org/10.1057/jors.2015.105.
- Bertsimas D, Boussioux L, Cory-Wright R, et al. From predictions to prescriptions: a data-driven response to COVID-19. Health Care Management Science. 2021;24:253–272. doi: https://doi.org/10.1007/s10729-020-09542-0.
- Fadaki M, Abareshi A, Far SM, Lee PTW. Multi-period vaccine allocation model in a pandemic: a case study of COVID-19 in Australia. Transportation Research Part E. 2022;161:102689. doi: https://doi.org/10.1016/j.tre.2022.102689.
- Jahani H, Chaleshtori AE, Khaksar SMS, Aghaie A, Sheu JB. COVID-19 vaccine distribution planning using a congested queuing system: a real case from Australia. Transportation Research Part E. 2022;163:102749. doi: https://doi.org/10.1016/j.tre.2022.102749.
- Gilani H, Sahebi H. A data-driven robust optimization model by cutting hyperplanes on vaccine access uncertainty in COVID-19 vaccine supply chain. Omega. 2022;110:102637. doi: https://doi.org/10.1016/j.omega.2022.102637.
- Wang X, Jiang R, Qi M. A robust optimization problem for drone-based equitable pandemic vaccine distribution with uncertain supply. Omega. 2023;119:102872. doi: https://doi.org/10.1016/j.omega.2023.102872.
- Mohammadi M, Dehghan M, Pirayesh A, Dolgui A. Bi-objective optimization of a stochastic resilient vaccine distribution network in the context of the COVID-19 pandemic. Omega. 2022;113:102725. doi: https://doi.org/10.1016/j.omega.2022.102725.
- Baloch G, Gzara F, Elhedhli S. COVID-19 PPE distribution planning with demand priorities and supply uncertainties. Computers & Operations Research. 2022;146:105913. doi: https://doi.org/10.1016/j.cor.2022.105913.
- Baloch G, Gzara F, Elhedhli S. Risk-based allocation of COVID-19 personal protective equipment under supply shortages. European Journal of Operational Research. 2023;310:1085–1100. doi: https://doi.org/10.1016/j.ejor.2023.04.001.
- Donmez Z, Turhan S, Karsu O, Kara BY, Karasan O. Fair allocation of personal protective equipment to health centers during early phases of a pandemic. Computers & Operations Research. 2022;141:105690. doi: https://doi.org/10.1016/j.cor.2021.105690.
- Emanuel EJ, Persad G, Kern A, et al. An ethical framework for global vaccine allocation. Science. 2020;369:1309–1312. doi: https://doi.org/10.1126/science.abe2803.
- Medlock J, Galvani AP. Optimizing influenza vaccine distribution. Science. 2009;325:1705–1708. doi: https://doi.org/10.1126/science.1175570.
- Nguyen C, Carlson JM. Optimizing real-time vaccine allocation in a stochastic SIR model. PLOS ONE. 2016;11:e0152950. doi: https://doi.org/10.1371/journal.pone.0152950.
Licence
© The Author(s) 2026. This article is open access under the CC BY 4.0 licence (https://creativecommons.org/licenses/by/4.0/), which permits use, sharing and reproduction provided the original work is properly cited.